heart failure, and hepatic and renal disease, including nephrotic syndrome in adults. INDICATION AND IMPORTANT SAFETY INFORMATION FOR ENBUMYST™ (BUMETANIDE NASAL SPRAY). INDICATION: ENBUMYST is indicated for the treatment of edema associated with...
or the regimen of 10 mg/kg once every two weeks may be continued. AD is a progressive, relentless disease characterized by formation of protein deposits known as plaques made of amyloid-beta aggregates and neurofibrillary tangles made of tau...
with heart failure with left ventricular ejection fraction (HF LVEF) ≥40% (10mg, 20mg, 40mg tablets) IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS: Hypersensitivity to any component of this product Concomitant use with strong CYP3A4 inhibitors...
improve patients' quality of life. By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. For more information, please visit www.bora-corp.com.
long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexP™-fusion and NexMab™ platform technology, respectively. It also developed a proprietary recombinant human hyaluronidase enzyme utilizing Hybrozyme™...
development, and potential therapeutic targets prior to intervention. Sanguine leverages its integrated technology platform to streamline data and donor engagement. By securely importing electronic medical records (EMRs) directly from clinic...
has been shown to increase branching of dendrites and synaptic plasticity signals.10 Indication and Important Safety Information for DAYBUE® (trofinetide) Indication DAYBUE is indicated for the treatment of Rett syndrome in adults and pediatric...
balanced between cohorts: median age was 65 years (range, 22-86); 66% male, 34% female; 96% of patients had an ECOG performance status of 0-1. PD-L1 expression data were collected from 83% of patients (69 of 83 patients) enrolled at U.S. sites and...
FORTE basket study, which includes BRAF V600 altered thyroid cancers, as we aim to generate further data to inform treatment and help patients with BRAF driven tumors.” The results presented at ATA 2025 are from 21 patients with thyroid cancer, 16...
aggregation and smooth muscle proliferation. Treprostinil is currently marketed by United Therapeutics in different dosage forms to alleviate the symptoms, maintain or improve functional class, delay disease progression, and improve quality of life...
Medicines Discovery Catapult (MDC) and Crown Bioscience have formed a strategic global collaboration to deliver an integrated translational biology platform for innovators developing radiopharmaceuticals. Radiopharmaceuticals are a growing class...
Marius Pharmaceuticals, Inc. announced a collaboration with Hims & Hers™, one of the largest digital health platforms for men, to make KYZATREX®, an FDA-approved oral testosterone replacement therapy for adult men with low or no testosterone...
Waldencast plc a global multi-brand beauty and wellness platform, announced that the U.S. Food and Drug Administration (“FDA”) has approved Obagi® saypha® MagIQ™ injectable hyaluronic acid (“HA”) gel, the first product in the Obagi® saypha®...
Avadel Pharmaceuticals plc a biopharmaceutical company focused on transforming medicines to transform lives, today announced that new data supporting the use of LUMRYZ as a narcolepsy treatment will be presented in one oral presentation and 16...
the recent approval of IBTROZI in the U.S., which has added an important new option for a range of patients with this form of lung cancer, regardless of prior exposure to tyrosine kinase inhibitor therapy.” “Disease progression remains one of the...
provide further evidence of the potential role that ifinatamab deruxtecan could play in treating this aggressive form of lung cancer.” The safety profile observed in IDeate-Lung01 was consistent with that seen for ifinatamab deruxtecan in the phase...
Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, announced that it will be issued U.S. Patent No....
Global Head of Swine at Boehringer Ingelheim. “We’ll continue to closely monitor PCV2 and other diseases impacting pig performance to help producers stay ahead of emerging risks.” A vaccine that provides broad cross-protection is essential for...
of the most advanced capsule filling and inhalation drug development capabilities in the industry. Innovative machine platforms and packaging systems ensure that Experic’s customers benefit from flexible, scalable solutions tailored to their needs....
StemSight, Rinri Therapeutics, and Novadip. Each company intends to integrate Mytos’ iDEM automated cell manufacturing platform to scale the production of diverse cell types for therapeutic use, highlighting the platform’s versatility to create...
